UnitedHealth Group Incorporated $UNH Shares Sold by Empirical Financial Services LLC d.b.a. Empirical Wealth Management

Empirical Financial Services LLC d.b.a. Empirical Wealth Management reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.3% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 11,858 shares of the healthcare conglomerate’s stock after selling 663 shares during the quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management’s holdings in UnitedHealth Group were worth $3,699,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the business. Retirement Planning Group LLC lifted its holdings in UnitedHealth Group by 5.1% during the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock worth $225,000 after buying an additional 21 shares in the last quarter. Net Worth Advisory Group raised its holdings in shares of UnitedHealth Group by 0.6% in the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock valued at $1,907,000 after purchasing an additional 21 shares in the last quarter. Bensler LLC raised its holdings in shares of UnitedHealth Group by 0.3% in the 1st quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock valued at $3,637,000 after purchasing an additional 22 shares in the last quarter. Lakeridge Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 5.8% in the 1st quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate’s stock valued at $220,000 after purchasing an additional 23 shares in the last quarter. Finally, Broadway Wealth Solutions Inc. raised its holdings in shares of UnitedHealth Group by 2.1% in the 1st quarter. Broadway Wealth Solutions Inc. now owns 1,151 shares of the healthcare conglomerate’s stock valued at $603,000 after purchasing an additional 24 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 1.8%

UNH stock opened at $360.17 on Friday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The stock has a market capitalization of $326.20 billion, a PE ratio of 15.61, a price-to-earnings-growth ratio of 2.30 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a fifty day moving average of $307.84 and a 200-day moving average of $355.58.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the business posted $6.80 EPS. The firm’s revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. Morgan Stanley increased their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Sanford C. Bernstein increased their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Royal Bank Of Canada dropped their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Barclays raised their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Finally, Robert W. Baird reissued an “underperform” rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.